CDC Website CDC Website

To Join the NPIN community or

Home » "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21)

"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21)

The purpose of this funding opportunity announcement (FOA) is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals. This FOA encourages high or medium priority AIDS research in areas such as the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both non-AIDS defining and AIDS-defining malignancies in populations with an underlying HIV infection. This FOA encourages research efforts that will (i) identify specific contributions resulting from HIV infection and its potential interaction with other pathogens for the development and pathogenesis of these cancers and (ii) provide information on the clinical outcomes of such cancers in the HIV-infected population. Ultimately, such efforts could inform screening approaches and therapies targeted to the HIV-infected population.

Funding Organization
Fund Location Notes
Eligible Organizations
Number of Awards Given

Minimum Amount: 


Maximum Amount: 


Average Amount: 


Award Amount: 

Award Amount Notes
The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.
Companion Funding Opportunity-PA-16-426, R01 Exploratory/Developmental Grant
Letter of Intent Date
Application Due Date
Award Date
Open Ended Date
Project Start Date
Application Contact
Read-Connole, Ph.D.
United States
(240) 276-6226
Read-Connole, Ph.D.
(240) 276-6226
Technical Contact
United States
(301) 710-0267
(301) 710-0267
Fund Duration
The maximum project period is 2 years.
Application Process
It is critical that applicants follow the instructions in the Research Instructions for the SF424 (R&R) Application Guide, including Supplemental Grant Application Instructions except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Focus Area

Fund Number: 


Fund ID: 


Last Updated: